A

Arrowhead Pharmaceuticals

D
ARWR
USD
0.805
(3.9116%)
Market Closed
51,460.00
Volume
-2.9825
EPS
-
Div Yield
-4.598925
P/E
2,658,482,134.49
Market Cap
Today
0.2579%
1 Week
11.206%
1 Month
17.824%
6 Months
-14.460%
12 Months
-22.236%
Year To Date
-30.114%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
C
CRSP
1.15
(2.2656%)
USD
E
EDIT
-0.11
(-3.3537%)
USD
N
NTLA
-0.05
(-0.3113%)
USD
REGN
REGN
8.505
(1.0417%)
USD
ALNY
ALNY
-0.795
(-0.2913%)
USD
D
DRNA
(%)
USD
S
SLDB
-0.37
(-6.0359%)
USD
MRNA
MRNA
-1.49
(-2.8776%)
USD
V
VYGR
-0.18
(-2.4759%)
USD

Title:
Arrowhead Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
Do you need help or have a question?
Contact Us